CEESAY ABRAHAM (Chief Executive Officer) sold 0.4% of their position (2.21K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $93.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/29/2026ACC: 0001193125-26-323637
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-2.21K
Net shares
Net seller
$93.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.20K
Price / share
$42.11
Trade value
$92.76K
% of position
0.4%
7/27/2026
539.82K→537.61K
Common Stock
Direct
Shares
−7.00
Price / share
$42.73
Trade value
$299.14
% of position
0.0%
7/27/2026
537.61K→537.61K
Total
Net shares
−2.21K
Net value
-$93.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/27/2026 | S · Sale | −2.20K | $42.11 | $92.76K | 0.4% | 539.82K | 537.61K |
| Common Stock Direct | 7/27/2026 | S · Sale | −7.00 | $42.73 | $299.14 | 0.0% | 537.61K | 537.61K |
| Total | −2.21K | -$93.06K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned81.73K
Common Stock
IndirectShares owned20.73K
Total
102.46K indirect102.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 81.73K | Indirect |
| Common Stock | 20.73K | Indirect |
| Total | 102.46K | 102.46K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported